Author profile
Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Harvard Medical School
To investigate whether the apparent diffusion coefficient (ADC) from diffusion-weighted imaging (DWI) acquired at a 0.35T MR-Linac can determine prostate and intraprostatic lesion changes caused by adaptive radiotherapy performed on this treatment modality.
We compared denoising methods for Diffusion-Weighted Imaging (DWI) of phantoms acquired on a low-field MR-Linac to determine which method best preserves Apparent Diffusion Coefficient (ADC) accuracy and image feature detection. Our goal was to quantify image...
To quantify organ-at-risk (OAR) sparing achievable using a hybrid approach combining conventional image-guided radiotherapy (IGRT) with a CT-guided online adaptive radiotherapy (CT-ART) cone-down boost for pelvic malignancies.
Adaptive MR-guided Stereotactic Body Radiation Therapy (MRg-SBRT) is an effective treatment for malignant pancreatic lesions. However, its implementation may be hindered by the presence of implants with scanning conditions interdicting body coil transmission...
To evaluate the correlation between lung tumor and pulmonary vessel motion under MR-guided radiotherapy and to inform surrogate tracking feature selection when direct tumor tracking is challenging.